Eric Fitzsimmons

Philadelphia

Senior editor at @CancerTodayMag. I write about cancer care and research for patients, survivors and caregivers. NJ raised, Philly based. Views are my own.

Featured in: Favicon

cancertodaymag.org Favicon

medium.com Favicon

delcotimes.com Favicon

trentonian.com Favicon

thereporteronline.com Favicon

dailylocal.com Favicon

pottsmerc.com Favicon

timesherald.com Favicon

montgomerynews.com Favicon

phoenixvillenews.com + 1 more

Articles

May 23: The Week in Cancer News

2 weeks ago | brnw.ch | Eric Fitzsimmons

Every week, the editors of Cancer Today magazine bring you the top news for cancer patients from around the internet. Stay up to date with the latest in cancer research and care by subscribing to our e-newsletter. Rising cases of extreme weather are forcing patients, clinics and researchers to consider how disasters and accompanying disruptions to treatment affect care. Medscape reported on the ways wildfires, heat waves and hurricanes can keep people from getting to treatment for a week or longer.
May 23: The Week in Cancer News

2 weeks ago | cancertodaymag.org | Eric Fitzsimmons

Every week, the editors of Cancer Today magazine bring you the top news for cancer patients from around the internet. Stay up to date with the latest in cancer research and care by subscribing to our e-newsletter. Rising cases of extreme weather are forcing patients, clinics and researchers to consider how disasters and accompanying disruptions to treatment affect care. Medscape reported on the ways wildfires, heat waves and hurricanes can keep people from getting to treatment for a week or longer.
May 16: The Week in Cancer News

3 weeks ago | brnw.ch | Eric Fitzsimmons

Every week, the editors of Cancer Today magazine bring you the top news for cancer patients from around the internet. Stay up to date with the latest in cancer research and care by subscribing to our e-newsletter. A study published in Nature Communications investigated the use of Lynparza (olaparib) in patients with early-stage breast cancer who have inherited BRCA1 or BRCA2 gene mutations.
Family of Henrietta Lacks Works for ‘Health Intelligence’

3 weeks ago | brnw.ch | Eric Fitzsimmons

ALFRED LACKS CARTER JR. is on a mission to foster “health intelligence” in communities of color. Carter comes from a family where the importance of understanding your health care has a special resonance: His grandmother was Henrietta Lacks, a cervical cancer patient whose cells were harvested and cultured without her knowledge. Lacks’ cells, called HeLa cells after the first two letters of her first and last names, are still used in medical research.
May 2: The Week in Cancer News

1 month ago | cancertodaymag.org | Eric Fitzsimmons

Every week, the editors of Cancer Today magazine bring you the top news for cancer patients from around the internet. Stay up to date with the latest in cancer research and care by subscribing to our e-newsletter. Surgery is a staple of early-stage cancer care, but select patients whose cancer responds to immunotherapy may not need to undergo an operation, according to a presented at the American Association for Cancer Research (AACR) Annual Meeting 2025 in Chicago.
Researchers Tackle Immune-related Adverse Effects

1 month ago | brnw.ch | Eric Fitzsimmons

APPROXIMATELY 40% of people with cancer who receive immune checkpoint inhibitors will experience immune-related adverse events (irAEs), ranging from mild symptoms of fatigue and rash to life-threatening conditions that can lead to hospitalizations and even death.
Tissue and Liquid Biopsy for Targeted Therapy

1 month ago | brnw.ch | Eric Fitzsimmons

PATIENTS EXPERIENCED longer survival and more time without cancer progressing when doctors used both liquid biopsy and traditional biopsy on tumor tissue to select tailored treatment, according to findings from the ROME study. Though treatment based on biomarkers detected in either blood or tumor tissue, but not both, were also associated with higher survival than standard of care in some cases, the largest increase in survival was in patients where the results of both tests agreed.
Tissue and Liquid Biopsy for Targeted Therapy

1 month ago | cancertodaymag.org | Eric Fitzsimmons

PATIENTS EXPERIENCED longer survival and more time without cancer progressing when doctors used both liquid biopsy and traditional biopsy on tumor tissue to select tailored treatment, according to findings from the ROME study. Though treatment based on biomarkers detected in either blood or tumor tissue, but not both, were also associated with higher survival than standard of care in some cases, the largest increase in survival was in patients where the results of both tests agreed.
Cancer Vaccines Show Promise in Early Trials

1 month ago | brnw.ch | Eric Fitzsimmons

CANCER VACCINATION offers the promise of training the body’s immune system to identify and attack cancer cells from within. While this technology is one of the most exciting topics in cancer research, many investigational vaccines have not been effective in human trials. But in the past decade, researchers have learned more about immunology, identified new targets and developed novel technologies, fueling optimism about this approach, according to Darrell J.
Missed Activities Due to Cancer-related Fatigue and Depression

1 month ago | brnw.ch | Eric Fitzsimmons

PHYSICAL ACTIVITY has been linked with a number of benefits, both physical and emotional, for cancer patients. But a study presented April 29 at the American Association for Cancer Research (AACR) Annual Meeting 2025 in Chicago found that cancer-related fatigue and depression were associated with decreased recreational physical activity and were more likely to affect women.